Condition: Ovarian Neoplasms · Sponsor: Instituto Nacional de Cancerologia de Mexico
This is a study that aims to demonstrate the non-inferiority of minimally invasive surgery versus open surgery, as an approach for patients with advanced ovarian cancer who received neoadjuvant chemotherapy, giving them the benefits of laparoscopic surgery. This way they can continue with their complementary treatment.
This description comes directly from the study's public registry record.
David Isla Ortiz, MD, M. Cs. · +52 55 1850 9654 · islasurgery@hotmail.com
Always discuss trial participation with your own doctor first.
| Instituto Nacional de Cancerologia | México, Tlalpan, Mexico | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06883409